Shingles: Rash Pattern, Contagion, and Key Facts

Shingles (herpes zoster) is reactivation of latent varicella-zoster virus (VZV) in dorsal root ganglia.

Rash Characteristics

  • Dermatomal distribution: Unilateral, band-like, typically thoracic (T3–L3) or cranial (V1 ophthalmic).
  • Progression: Macules → vesicles (clustered on erythematous base) → pustules → crusts (7–10 days).
  • Pain: Often precedes rash by days (prodrome); can be severe, burning, neuropathic.

Contagion

  • Not spread person-to-person as shingles.
  • VZV in vesicle fluid can infect a non-immune person → they develop chickenpox (varicella), not shingles.
  • Airborne spread possible (especially disseminated zoster); contact precautions until crusting.
  • Cover rash; avoid contact with pregnant, immunocompromised, neonates.

Complications

  • Postherpetic neuralgia (PHN): Pain >90 days after rash; risk ↑ with age.
  • Ophthalmic zoster (V1): keratitis, uveitis, vision loss—ophthalmology emergency.
  • Ramsay Hunt (CN VII): facial palsy, ear vesicles, hearing loss.
  • Disseminated zoster: immunocompromised; visceral involvement.

Prevention & Treatment

  • Shingrix (RZV): 2-dose recombinant subunit vaccine; >90% efficacy; recommended ≥50 (or ≥19 immunocompromised).
  • Antivirals (valacyclovir 1g TID × 7d): Start within 72h of rash; reduce duration, severity, PHN risk.
  • Pain management: gabapentinoids, TCAs, topical lidocaine/capsaicin.

Sprains - Related Articles